Durect corporation to sell its lactel® absorbable polymer product line to evonik for $15 million

Cupertino, calif., dec. 7, 2020 /prnewswire/ -- durect corporation (nasdaq: drrx) today announced that it has signed an agreement to sell its lactel absorbable polymer (lactel) product line to evonik, a global leader in specialty chemicals. under the terms of the agreement, evonik will...
DRRX Ratings Summary
DRRX Quant Ranking